Spectral Diagnostics (OTCMKTS:EDTXF) Stock Price Down 0.3% – Here’s Why

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) shares traded down 0.3% on Wednesday . The company traded as low as $0.9830 and last traded at $0.9830. 21,191 shares were traded during trading, an increase of 187% from the average daily volume of 7,392 shares. The stock had previously closed at $0.9860.

Spectral Diagnostics Stock Performance

The company has a 50 day simple moving average of $0.98 and a two-hundred day simple moving average of $0.99. The firm has a market cap of $290.32 million, a PE ratio of -9.89 and a beta of 0.11.

Spectral Diagnostics (OTCMKTS:EDTXF) last released its earnings results on Friday, May 8th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). The firm had revenue of $0.64 million for the quarter, compared to analyst estimates of $0.54 million.

Spectral Diagnostics Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.